Form EFFECT BridgeBio Oncology Thera
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 10, 2025 4:01 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- REGENXBIO Reports Second Quarter 2026 Financial Results and Operational Highlights
- Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board
- Kelt Reports Financial and Operating Results for the Three Months Ended June 30, 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
